Abstract: Disclosed herein is a method or a pharmaceutical composition for the treatment of dry eye disease or corneal wound healing, comprising administering to a subject in need thereof a therapeutically effective amount of secretome of amniotic fluid stem cells. Also provided is a use of secretome of amniotic fluid stem cells for manufacturing a medicament for the treatment of dry eye disease or corneal wound healing.
Type:
Application
Filed:
July 15, 2024
Publication date:
January 9, 2025
Applicant:
U-Neuron Biomedical Inc.
Inventors:
Shiaw-Min Hwang, Chen-An Hsieh, Pei-Cheng Lin
Abstract: Disclosed herein is a method or a pharmaceutical composition for the treatment of dry eye disease or corneal wound healing, comprising administering to a subject in need thereof a therapeutically effective amount of secretome of amniotic fluid stem cells. Also provided is a use of secretome of amniotic fluid stem cells for manufacturing a medicament for the treatment of dry eye disease or corneal wound healing.
Type:
Application
Filed:
June 1, 2021
Publication date:
December 1, 2022
Applicant:
U-Neuron Biomedical Inc.
Inventors:
Shiaw-Min Hwang, Chen-An Hsieh, Pei-Cheng Lin
Abstract: Disclosed herein is a use of an amniotic fluid stem cell spheroid in the preparation of a composition or pharmaceutical composition for treating urinary incontinence, wherein said pharmaceutical composition may further comprise hyaluronic acid.
Type:
Application
Filed:
December 10, 2020
Publication date:
March 17, 2022
Applicant:
U-Neuron Biomedical Inc.
Inventors:
Shiaw-Min Hwang, Shing-Hwa Lu, Kuei-Chang Li, Wei-Ti Wang